EPISBS Stock Overview
A medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Episurf Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.24 |
| 52 Week High | SEK 0.24 |
| 52 Week Low | SEK 0.24 |
| Beta | 1.03 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| EPISBS | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -6.6% | -0.9% |
| 1Y | n/a | -1.7% | 8.6% |
Return vs Industry: Insufficient data to determine how EPISBS performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how EPISBS performed against the UK Market.
Price Volatility
| EPISBS volatility | |
|---|---|
| EPISBS Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 9.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: EPISBS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EPISBS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 26 | Pal Ryfors | episurf.com |
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also provides Episealer Talus, a solution for the treatment of bone and cartilage defects in the talus bone of the ankle joint; Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning.
Episurf Medical AB (publ) Fundamentals Summary
| EPISBS fundamental statistics | |
|---|---|
| Market cap | SEK 97.33m |
| Earnings (TTM) | -SEK 84.70m |
| Revenue (TTM) | SEK 11.70m |
8.3x
P/S Ratio-1.1x
P/E RatioIs EPISBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EPISBS income statement (TTM) | |
|---|---|
| Revenue | SEK 11.70m |
| Cost of Revenue | SEK 52.40m |
| Gross Profit | -SEK 40.70m |
| Other Expenses | SEK 44.00m |
| Earnings | -SEK 84.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 25, 2024
| Earnings per share (EPS) | -0.13 |
| Gross Margin | -347.86% |
| Net Profit Margin | -723.93% |
| Debt/Equity Ratio | 0% |
How did EPISBS perform over the long term?
See historical performance and comparison